Mark your calendars for the Workshop on Improved Characterization of Mesenchymal Stem Cells for Clinical Trials, sponsored by the University of Maryland Center for Excellence in Regulatory Science and Innovation, the University of Maryland School of Medicine's Center for Stem Cell Biology and Regenerative Medicine and Department of Orthopaedics, and the Food and Drug Administration.
About the Event:
Multipotent mesenchymal stromal cell (MSC)-based cellular therapies hold great potential for the treatment of a wide array of medical conditions. However, MSCs are so novel that product characterization can be particularly challenging. For clinical use, current approaches to the characterization of human MSCs rely mostly on a few cell surface markers and qualitative, imprecise measures of cell activity. Optimal approaches to evaluation and selection of in-process or lot release tests that will predict the in vivo performance of cell-based therapies reliably remain unknown.
The Workshop on Improved Characterization of Mesenchymal Stem Cells for Clinical Trials will be held on Wednesday, May 8, 2013, in the Southern Management Corporation Campus Center at the University of Maryland, Baltimore, located at 621 West Lombard Street in Baltimore, MD. The goal of this workshop is to assess MSC characterization and discuss methods that can be used to predict the quality, potency, and safety of MSCs, with implications for other types of stem cells and cell-based products. This workshop is sponsored by the University of Maryland Center for Excellence in Regulatory Science and Innovation (M-CERSI), the University of Maryland School of Medicine's Center for Stem Cell Biology and Regenerative Medicine and Department of Orthopaedics, and the Food and Drug Administration (FDA).
About the Sponsor:
 |
The Center of Excellence in Regulatory Science and Innovation (CERSI) focuses on modernizing and improving the ways in which drugs and medical devices are developed and evaluated. It is a collaborative partnership between the Food and Drug Administration (FDA) and the Baltimore and College Park campuses of the University of Maryland. |
 |
Established in 2009, the Center for Stem Cell Biology and Regenerative Medicine provides a focal point of interaction, information, leadership, and facilitation of stem cell research and regenerative medicine applications at the University of Maryland, with links to Johns Hopkins, federal laboratories, and corporate researchers across the state of Maryland. |
For More Information:
More information, including registration, agenda, accommodations, and parking and directions, can be found on this website.